Investigative Medicine Program
This highly innovative program awards a PhD degree in Investigative Medicine to physicians training in either laboratory-based or clinically-based patient-oriented research. It has been expanded under the Clinical and Translational Science Award (CTSA) to include scholars in nursing, public health, biomedical engineering, and biological and biomedical sciences who are seeking a PhD with a focus in clinical investigation. IMP also serves as a vehicle for integrating student training; many other individuals (medical, nursing and graduate students, residents, as well as clinical fellows and junior faculty members, some of whom are YCCI Scholars) take courses offered by the IMP each year.
A total of 40 trainees have matriculated since the IMP began admitting students in July 2000. The program currently admits five to six new students per year. In addition, approximately 250 trainees from other programs and faculty members take IMP courses annually. IMP trainees are typically supported by institutional T32 awards or by institutional funds (necessary for those who are not US citizens or permanent residents) during their first two to three years of training in the IMP, analogous to biomedical science graduate students at Yale. After this, they are generally supported by their own grants or by departmental sources. Alumni have gone on to academic positions at Yale, Boston University, University of Chicago, Duke NUS Graduate Medical School – Singapore, University of New Mexico, Memorial Sloan-Kettering Cancer Center, University of Pittsburgh, University of Texas Health Science Center at San Antonio, University of Pennsylvania School of Medicine, Cleveland Clinic Foundation and Hadassah Hebrew University School of Medicine.
Click here for a list of representative publications.